Verve Therapeutics
Verve Therapeutics Logo
About Verve Therapeutics
Verve Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing gene editing medicines for the treatment of cardiovascular disease. The company is advancing a pipeline of single-course in vivo gene editing programs designed to inactivate genes in the liver that contribute to cardiovascular risk, such as PCSK9, ANGPTL3, and LPA. Verve Therapeutics aims to transform the treatment paradigm for cardiovascular disease by providing durable, potentially lifelong solutions for patients. The company is headquartered in Boston, Massachusetts, and serves customers worldwide.
Address
201 Brookline Avenue, Suite 601
Boston, 02215
United States
Year founded
2018
Number of employees
200-300
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
